Borje S Andersson (B S Andersson)

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 13

Top Topics

Advanced Cancer

Peritoneal Dialysis

Stem Cell Transplantation

Prognostic Factors

Top Venues

Bone marrow transplantation

Human vaccines & immunotherapeutics

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Sabine Fürst, Emmanuelle Bernit, Faezeh Legrand, Angela Granata, Samia Harbi, Raynier Devillier, Valerio Maisano, Benjamin Bouchacourt, Thomas Pagliardini, Djamel Mokart, Claude Lemarié, Boris Calmels, Christophe Picard, Agnès Basire, Borje S Andersson, Didier Blaise
Durable engraftment after pharmacological pre-transplant immune suppression followed by reduced-toxicity myeloablative haploidentical stem cell transplantation in highly HLA-immunized adults with sickle cell disease. Bone marrow transplantation (2024)
Sabine Fürst, Emmanuelle Bernit, Faezeh Legrand, Angela Granata, Samia Harbi, Raynier Devillier, Valerio Maisano, Benjamin Bouchacourt, Thomas Pagliardini, Djamel Mokart, Claude Lemarié, Boris Calmels, Christophe Picard, Agnès Basire, Borje S Andersson, Didier Blaise
Durable engraftment after pharmacological pre-transplant immune suppression followed by reduced-toxicity myeloablative haploidentical stem cell transplantation in highly HLA-immunized adults with sickle cell disease. Bone marrow transplantation 59 (7) (2024)
Sabine Fürst, Emmanuelle Bernit, Faezeh Legrand, Angela Granata, Samia Harbi, Raynier Devillier, Valerio Maisano, Benjamin Bouchacourt, Thomas Pagliardini, Djamel Mokart, Claude Lemarié, Boris Calmels, Christophe Picard, Agnès Basire, Borje S Andersson, Didier Blaise
Durable engraftment after pharmacological pre-transplant immune suppression followed by reduced-toxicity myeloablative haploidentical stem cell transplantation in highly HLA-immunized adults with sickle cell disease. Bone marrow transplantation (2024)
Apostolia-Maria Tsimberidou, Mehmet A Baysal, Abhishek Shankar, Borje S Andersson
Autologous engineered T cell receptor therapy in advanced cancer. Human vaccines & immunotherapeutics 19 (3) (2023)
Jeremy L Ramdial, B C Valdez, Borje S Andersson, Y Nieto
Romidepsin antagonism with CHOEP. Leukemia (2023)
Apostolia-Maria Tsimberidou, Kerstin Guenther, Borje S Andersson, Regina Mendrzyk, Amir Alpert, Claudia Wagner, Anna Nowak, Katrin Aslan, Arun Satelli, Fabian Richter, Sabrina Kuttruff-Coqui, Oliver Schoor, Jens Fritsche, Zoe Coughlin, Ali S Mohamed, Kerry Sieger, Becky Norris, Rita Ort, Jennifer Beck, Henry Hiep Vo, Franziska Hoffgaard, Manuel Ruh, Linus Backert, Ignacio I Wistuba, David Fuhrmann, Nuhad K Ibrahim, Van Karlyle Morris, Bryan K Kee, Daniel M Halperin, Graciela Nogueras Gonzalez, Partow Kebriaei, Elizabeth J Shpall, David J Vining, Patrick Hwu, Harpreet Singh-Jasuja, Carsten Reinhardt, Cedrik M Britten, Norbert Hilf, Toni Weinschenk, Dominik Maurer, Steffen Walter
Feasibility and Safety of Personalized, Multi-Target, Adoptive Cell Therapy (IMA101): First-In-Human Clinical Trial in Patients with Advanced Metastatic Cancer. Cancer immunology research (2023)
Apostolia-Maria Tsimberidou, Mehmet A Baysal, Abhishek Shankar, Borje S Andersson
Autologous engineered T cell receptor therapy in advanced cancer. Human vaccines & immunotherapeutics 19 (3) (2023)
Apostolia-Maria Tsimberidou, Mehmet A Baysal, Abhishek Shankar, Borje S Andersson
Autologous engineered T cell receptor therapy in advanced cancer. Human vaccines & immunotherapeutics 19 (3) (2023)
Jeremy L Ramdial, K H Chan, G Sanchez Petitto, B Valdez, Borje S Andersson, Y Nieto
Intravenous Busulfan, Dimethylacetamide and neurotoxicity after high-dose pretransplant conditioning chemotherapy. Bone marrow transplantation (2023)
Apostolia-Maria Tsimberidou, Mehmet A Baysal, Abhishek Shankar, Borje S Andersson
Autologous engineered T cell receptor therapy in advanced cancer. Human vaccines & immunotherapeutics 19 (3) (2023)
Apostolia-Maria Tsimberidou, Mehmet A Baysal, Abhishek Shankar, Borje S Andersson
Autologous engineered T cell receptor therapy in advanced cancer. Human vaccines & immunotherapeutics 19 (3) (2023)
Borje S Andersson, Peter F Thall, Junsheng Ma, Benigno C Valdez, Roland L Bassett, Julianne Chen, Sairah A Ahmed, Amin M Alousi, Qaiser Bashir, Stefan Ciurea, Alison Gulbis, Rita Cool, Jitesh Kawedia, Chitra Hosing, Partow Kebriaei, Steven Mitchell Kornblau, Alan Myers, Betul Oran, Katayoun Rezvani, Nina Shah, Elizabeth Shpall, Simrit Parmar, Uday R Popat, Yago Nieto, Richard E Champlin
A randomized phase III study of pretransplant conditioning for AML/MDS with fludarabine and once daily IV busulfan ± clofarabine in allogeneic stem cell transplantation. Bone marrow transplantation 57 (8) (2022)
Amanda Olson, Ruitao Lin, David Marin, Hind Rafei, Mustafa H Bdaiwi, Peter F Thall, Rafet Basar, Ala Abudayyeh, Pinaki Banerjee, Fleur M Aung, Indresh Kaur, Glorette Abueg, Sheetal Rao, Roy F Chemaly, Victor Mulanovich, Gheath Al-Atrash, Amin M Alousi, Borje S Andersson, Paolo Anderlini, Qaiser Bashir, Karla M Castro, May Daher, Isabel M Galvan, Chitra Hosing, Jin S Im, Roy B Jones, Partow Kebriaei, Issa F Khouri, Rohtesh S Mehta, Jeffrey Molldrem, Yago L Nieto, Betül Oran, Sairah A Ahmed, Muzaffar Qazilbash, Gabriela Rondon, Neeraj Saini, Bryan Spencer, Samer Srour, Dominique Washington, Melissa Barnett, Richard E Champlin, Elizabeth J Shpall, Katayoun Rezvani
Third-Party BK Virus-Specific Cytotoxic T Lymphocyte Therapy for Hemorrhagic Cystitis Following Allotransplantation. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 39 (24) (2021)